choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Bystolic

Bystolic Newsletter
  • Second Circuit dismisses suit against drugmaker that paid competitors to delay generic release 13 May 2024 21:45 GMT

    … year blood pressure treatment, Bystolic. They claim that … market release of the drug. Forest Laboratories' competitors, including Hetero … another company, Janssen Pharmaceutical NV, seven months earlier … latest about ongoing trials, major litigation and …

  • Second Circuit scraps Bystolic pay-for-delay claims 14 May 2024 02:50 GMT

    … off generic drugmakers to keep away from its Bystolic hypertension drug, the US …

  • Pay for Delay is Sometimes Okay 23 May 2024 18:23 GMT

    … of a patented drug. CVS Pharmacy, Inc. v. Forest Labs. Inc., Case … .) This case involves a drug called Bystolic, which is a beta blocker … active pharmaceutical ingredients or finished pharmaceutical products was consistent with what Forest Labs. disclosed …

  • In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit 13 May 2024 22:14 GMT

    … lawsuit alleged that the Bystolic patentholder, Forest Labs (now a part … settlement payments to generic-drug manufacturers were “unjustified” … settlement with seven generic-drug manufacturers, Forest agreed … as ingredients for the drug’s manufacture. Plaintiffs …

  • FTC Files Amicus Brief in Bystolic Antitrust Litigation Supporting Competition in the Hypertension Drug Market 21 Jun 2023 06:01 GMT

    … the pharmaceutical sector. The case relates to Forest Laboratories Inc. and six generic drug … manufacturers’ alleged efforts to delay competition with Bystolic, Forest … plaintiffs, which are purchasers of Bystolic, allege that Forest used the …

  • ANI Pharmaceuticals Reports Third Quarter 2021 Results 01 Nov 2021 10:45 GMT

    … S. Food and Drug Administration (FDA) approved the Company … Cortrophin Gel) for the treatment of certain chronic autoimmune … the reference listed drug (RLD) Bystolic®. Third Quarter 2021 … pharmaceutical products, including for diseases with high unmet medical …

  • ANI Pharmaceuticals Announces Launch of Nebivolol Tablets 17 Sep 2021 11:14 GMT

    … the reference listed drug ("RLD") Bystolic(R). The current … U.S. market for Bystolic 2.5 mg, 5 … Pharmaceuticals, Inc. About Nebivolol Tablets Nebivolol Tablets are indicated for the treatment … U.S. Food and Drug Administration; general business and …

  • ANI Pharmaceuticals Announces Launch of Nebivolol Tablets 17 Sep 2021 10:50 GMT

    … of the reference listed drug (“RLD”) Bystolic®. The current annual U … .S. market for Bystolic 2.5 mg, 5 … Pharmaceuticals, Inc. About Nebivolol Tablets Nebivolol Tablets are indicated for the treatment … U.S. Food and Drug Administration; general business and …

  • Top Drugs Losing Patent Exclusivity in 2021 29 Apr 2021 06:57 GMT

    … treatment of wet age-related forms of the disease (AMD). Bystolic … of the drug can come on the market (if FDA approved) … ANDA litigation action against Hikma Pharmaceuticals (see "Amarin Pharma, … anemia marketed by Amag Pharmaceuticals.  Under the terms of …

  • Drug makers quietly raised prices on hundreds of medications – again 04 Mar 2021 11:44 GMT

    … — The two white pills sitting in the palm … Examples include blood pressure medication Bystolic (approximately $170 for … drug prices, little price regulation and limited competition in the pharmaceutical … approval from the doctor. Generic medications use the same …

Satisfied with the content?

Continue to create your account.